Our work highlights the HSF1 pathway as a therapeutic target in ALS patients with DNAJC7 mutations, and perhaps beyond68, as RNA-Seq analysis revealed a reduction in the expression of HSF1 pathway genes in sporadic and C9orf72 patient neurons. The gene discussed is DNAJC7; the disease is amyotrophic lateral sclerosis.